Current role
Yat Sun Or
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Enanta Pharmaceuticals Inc (ENTA)
Proxy statement
Current
Company network
Recorded roles and earnings-call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Enanta Pharmaceuticals Inc (ENTA) | Chief Scientific Officer | $553,150 | $1,293,790 |
| 2024 | Enanta Pharmaceuticals Inc (ENTA) | Chief Scientific Officer | $537,050 | $1,222,705 |
| 2023 | Enanta Pharmaceuticals Inc (ENTA) | Chief Scientific Officer | $501,250 | $2,469,600 |
| 2022 | Enanta Pharmaceuticals Inc (ENTA) | Chief Scientific Officer | $486,525 | $1,992,111 |
| 2021 | Enanta Pharmaceuticals Inc (ENTA) | Chief Scientific Officer | $486,525 | $1,992,111 |
| 2020 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Research & Development and Chief Scientific Officer | $472,075 | $1,844,801 |
| 2019 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Research & Development, Chief Scientific Officer | $453,900 | $1,630,814 |
| 2018 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Research & Development and Chief Scientific Officer | $400,975 | $1,763,435 |
| 2017 | Enanta Pharmaceuticals Inc (ENTA) | Senior Vice President, Research & Development and Chief Scientific Officer | $400,975 | $1,763,435 |
Recent activity
No earnings-call appearances or filed executive changes recorded yet.